Vitro's Cancer Stem Cell Therapy Complements New Hedge Hog Drugs
Vitro's Cancer Stem Cell Therapy Complements New Hedge Hog Drugs Vitro Biopharma announces commercial availability of "Tools for Stem Cell and Drug DevelopmentTM" including products for use in cancer stem cell research. Vitro also owns proprietary technology for cancer stem cell therapy and this technology complements newly developed drugs that block a biological pathway (hedge hog) that drives the proliferation of cancer stem cells. Golden, CO (PRWEB) September 9, 2009 -- Vitro Diagnostics, Inc. (OTCBB: VODG), dba Vitro Biopharma,
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Categories
- Articles 313
- Bankruptcy 44
- Business 135
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 58
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 609
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4